NCT04195789Completed
Assessment of Interstitial Lung Disease in Rheumatoid Arthritis by Lung Ultrasound
Source: ClinicalTrials.gov · Last updated 10 Oct 2024
Brief summary (registry, in English)
The high resolution chest scan is the gold standard for the screening of interstitial lung disease, but this remains an onerous examination, and irradiating. Ultrasound could be used to detect these disorders with a very good sensitivity and specificity. This exam offers the advantage of being non radiating, inexpensive, and accessible to the rheumatologist who already uses it in their daily practice. The investigators want to assess the lung ultrasound performance compared with the gold standard. Patients will be included during a regular follow-up consultation with their referent rheumatologist. If there is an indication of first line biotherapy or targeted therapy the doctor will propose to the patient to participate in the study, give him the information leaflet, collect orally non-opposition, and will complete a survey for evaluation of the general health and potential risk factors for interstitial lung.
- Status (registry)
- Completed
- Study type
- Observational
- Enrollment
- 34 (actual)
- First submitted
- 10 Dec 2019
- Start date
- 4 Aug 2020
- Primary completion date
- 4 May 2024
- Lead sponsor
- Hospices Civils de Lyon
- Diseases
- Rheumatoid arthritis
- NCT number
- NCT04195789
What you commit to
- Study type: Observational
- Participants enrolled: 34
- From 4 Aug 2020 to the primary completion date, 4 May 2024
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- Known pulmonary disease that can alter lung interstitium: cardiac decompensation, COPD (chronic obstructive pulmonary disease), thoracic surgery, infection pulmonary
- Patient with respiratory functional signs suggestive of PID (Diffuse interstitial lung disease)
- Patient with signs of cardiac decompensation
- Psychiatric pathology seriously hindering understanding
Other
- Refusal to participate in the study
- Patient with pulmonary auscultation suggestive of PID
- Pregnant or lactating woman
- Difficulty understanding oral French
- Person deprived of liberty or under legal protection
Who the study is looking for
- Men and women over the age of 18
- With rheumatoid arthritis meeting the criteria ACR (American College of Rheumatology)/ EULAR (EUropean League Against Rheumatism) 2010
- Never received any biotherapy or targeted therapy
- Having an indication of introduction of biotherapy or therapy targeted (JAK inhibitors) (JAK : Janus kinase)
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Service de Rhumatologie. Centre hospitalier Lyon Sud. 69310 Coordinator of this site? Confirm its status | Pierre-Bénite | France | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.